HOW CAN YOU TELL WHETHER AN ACQUISITION REALLY CREATES VALUE?
An acquisition creates value when its expected economic benefit justifies the total capital, risk and integration effort compared with realistic alternatives. Purchase price alone is insufficient: the case needs strategic fit, complete funding requirements, testable synergy assumptions and a sustainable funding mix. Before proceeding, shareholders should establish whether the rationale holds if synergies arrive late or performance falls short, while keeping the option not to acquire explicitly on the table.
Judge an acquisition against its full capital commitment and alternatives, not the apparent attraction of its purchase price.
An acquisition competes with other uses of capital.
An acquisition creates value only when the expected economic benefit justifies the total capital committed, risk and execution burden compared with realistic alternatives. Strategic fit is necessary but insufficient. A useful capability may still be unattractive to acquire if its total cost or integration demands absorb the contribution it is expected to make.
Before a transaction begins, shareholders and the CEO should identify the industrial problem being solved. Access to customers, expertise, production capacity or a new geography each requires different evidence. Organic growth, partnerships, investment in the existing business and waiting should remain explicit alternatives. An acquisition should not become the default answer simply because an opportunity is available.
Move from purchase price to the full commitment.
Purchase price is one part of the decision. The economic picture must reflect the contemplated structure, avoiding double-counting debt, cash or other items already recognised. Transaction expenses, financing costs, possible subsequent payments, necessary capital expenditure and operating funding needs can materially change the resources required. Uncertainty about the structure should remain visible rather than be hidden inside a single total.
Systems migration, organisational changes, retention of key people and potential service disruption also belong in the assessment. Some costs are initial, others recurring; some are committed, others contingent. Separating them makes the expenditure timetable and peak cash requirement clearer. An acquisition that appears affordable at completion may still impose a demanding funding burden during the period in which benefits are being built.
Compare returns on a consistent economic basis.
Expected economic return should be based on cash flows consistent with the capital being assessed and the decision horizon. Higher revenue or EBITDA does not establish attractiveness if it requires additional investment or working capital. Assumptions about future value must also be visible; an eventual exit should not be expected to compensate automatically for weak operating economics.
The distinction between DCF and multiples helps explain valuation perspectives, but does not decide which use of capital is preferable. Alternatives should be compared for timing, risk, reversibility and management capacity consumed. A partnership may offer a less committed route; internal investment may take longer. Neither is inherently superior without examining what it delivers and what the company must give up.
Synergies require actions, ownership and time.
Synergies should be tied to specific interventions. Purchasing changes, shared distribution and integrated processes require compatible contracts, systems, people and decision rights. Benefits under management's control should be separated from those dependent on customers, suppliers or market behaviour. The expenditure needed to achieve each benefit belongs in the same plan.
If synergies arrive later than expected, initial costs and financing obligations may still arise on schedule. The delay reduces the contribution within the expected period and extends the cash requirement. Management must establish whether the business can carry that gap without diverting resources from essential activities. A plausible benefit at steady state does not, by itself, make the transition affordable or justify assuming that the original timetable will be recovered.
Consider performance shortfall before relying on recovery.
The downside assessment should begin with the acquired business on a standalone basis. Customer losses, departures of key people, weaker margins or higher working capital can reduce cash before integration delivers benefits. It is particularly important to establish whether the same event could affect both companies, limiting the diversification that the acquisition was expected to provide.
The plan should distinguish a recoverable delay from the loss of the original industrial rationale. In the latter case, continuing to fund the project to defend the initial decision may deepen the exposure. Corrective options need realistic constraints: changing the integration approach, reducing the scope or considering disposal carries costs and takes time. An exit cannot be treated as immediate, certain or available on the original assumptions.
Funding and integration capacity must work together.
The funding mix should be tested against the complete timetable, not merely its ability to cover the purchase price. Existing obligations, the acquired company's operating needs and investment elsewhere in the group compete for cash. A structure that needs synergies to arrive precisely on schedule warrants particular scrutiny of the flexibility left available if the plan slips.
Management attention is also finite. The assessment should identify who will lead integration, who will protect ordinary operations and which capabilities or decision rights are missing. Performance Improvement can inform the operating conditions and expected benefits, without promising an outcome. Time diverted from other initiatives is part of the opportunity cost. Ignoring it can make an acquisition appear less demanding than it will be in practice.
Set decision conditions before transaction execution.
The decision should specify conditions for proceeding, investigating further or declining, with accountable owners and review points. Changes in cost, synergy timing, customer continuity or liquidity should be capable of reopening the judgement. Initial approval does not make new evidence irrelevant. Explicit review and exit considerations reduce the risk of continuing solely because capital and reputation have already been committed.
Strategic Advisory owns this preliminary assessment of industrial coherence and capital allocation. It is not investment banking, brokerage, placement or advice on financial instruments, nor an offer of M&A execution services. For the shareholder, the conclusion is to proceed when the economic case remains credible after considering total capital, alternatives and downside, rather than because the purchase price appears attractive in isolation.
From industrial rationale to the pre-deal decision
Which objective requires an acquisition?
Compare the rationale with internal growth, partnerships and the option to wait.
What is the complete capital commitment?
Include costs, investment and integration needs, using cash flows and expected returns on a consistent basis.
What if synergies are late or performance falls short?
Test initial costs, delayed benefits, funding sustainability and management capacity together.
What would justify proceeding or reconsidering?
Specify missing evidence, accountability and review or withdrawal conditions before transaction execution.
The best decisions begin with the right questions.
Mizzau & Partners selectively works with entrepreneurs, boards and management teams on decisions that can change the trajectory of a business.
START A DIALOGUE